Business
Veracyte to Release Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026
SOUTH SAN FRANCISCO, Calif., February 04, 2026--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, announced today that it will release financial results for the fourth quarter and full-year 2025 after the close of market on Wednesday, February 25, 2026. Company management will host a conference call and webcast to discuss financial results and provide a general business update at 4:30 p.m. Eastern Time on the same day.
About this update from Veracyte, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":4609,"height":986,"url":"https://media.zenfs.com/en/business-wire.com/93ec40c51de2f607b0333e32bd7245e1"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/mtNxojB_6YaQhu52MgPlwg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTIwNTtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/93ec40c51de2f607b0333e32bd7245e1","width":960,"height":205},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/B5X87H.klpUbCcYwvhSfCg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD01MTQ7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/93ec40c51de2f607b0333e32bd7245e1","width":1200,"height":257}},"lazy":false},{"type":"text","content":"SOUTH SAN FRANCISCO, Calif., February 04, 2026--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, announced today that it will release financial results for the fourth quarter and full-year 2025 after the close of market on Wednesday, February 25, 2026. Company management will host a conference call and webcast to discuss financial results and provide a general business update at 4:30 p.m. Eastern Time on the same day.","length":458,"tagName":"p"},{"type":"text","content":"The conference call will be webcast live from the company’s website and will be available via the following link: https://edge.media-server.com/mmc/p/motsphxv. A webcast replay will be available following the conclusion of the live broadcast and will be accessible on the company’s website at https://investor.veracyte.com/events-presentations.","length":344,"tagName":"p"},{"type":"text","content":"The conference call dial-ins can be accessed by registering via this link.","length":74,"tagName":"p"},{"type":"text","content":"About Veracyte","length":14,"tagName":"p"},{"type":"text","content":"Veracyte (Nasdaq: VCYT) is a global diagnostics company whose vision is to transform cancer care for patients all over the world. We empower clinicians with the high-value insights they need to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. Our Veracyte Diagnostics Platform delivers high-performing cancer tests that are fueled by broad genomic and clinical data, deep bioinformatic and AI capabilities, and a powerful evidence-generation engine, which ultimately drives du...